Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000823230> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2000823230 abstract "Dietary supplements and botanical products are widely used by patients diagnosed with prostate cancer (CaP) as a primary or adjuvant form of treatment for their medical conditions in the United States. Many of the available products are complex mixtures composed of extracts from foreign plants, whose mechanism of action typically is not systematically and rigorously investigated. Laboratory studies employing precisely defined conditions and referenced methodologies are essential not only for standardization and characterization of the products, but are also important requisites for providing scientific evidence and molecular insights in regard to the clinical efficacies some of these products purportedly demonstrate. In previous studies from this laboratory, we serendipitously observed that Equiguard, a dietary supplement formulated with extracts from nine Chinese herbs for preventing decline in renal functions associated with the aging process, contain 70% ethanol-extractable ingredients that displayed potent growth inhibitory activities in androgen-dependent (AD) LNCaP and androgen-independent (AI) DU-145 and PC-3 cells. Moreover, significant reduction in expression of the androgen receptor (AR) and prostate specific antigen (PSA) also occurred in Equiguard-treated LNCaP cells. Although these results offer the possibility that Equiguard confers chemoprevention for CaP, it remains undetermined whether Equiguard functions in CaP cell types that represent the transition of AD to the AI status. Further, details of its mechanism of action have not been fully elucidated. The studies described in this report focusing on CWR22Rv1 cells are intended to fill these gaps. These cells express AR and PSA, yet show weak responsiveness to androgens and largely proliferate in an AI-independent manner - features that mimic AD --> AI in clinically advanced disease. Using the CWR22Rv1 cells, we showed that 70% ethanolic extracts of Equiguard effectively suppressed colony formation, inhibited cell proliferation, reduced expression of cell cycle regulatory proteins including cyclin D1, E2F, as well as lowered AR and PSA levels. Treatment of CWR22Rv1 cells with Equiguard also decreased cyclooxygenase 2 and led to increases in quinone reductase 1 and 2. These results provide further support that Equiguard possess multiple, chemopreventive attributes capable of disrupting the transition of AD --> AI in clinically advanced CaP." @default.
- W2000823230 created "2016-06-24" @default.
- W2000823230 creator A5006685141 @default.
- W2000823230 creator A5068782556 @default.
- W2000823230 date "2008-01-01" @default.
- W2000823230 modified "2023-10-18" @default.
- W2000823230 title "Ethanolic extracts of herbal supplement Equiguard™ suppress growth and control gene expression in CWR22Rv1 cells representing the transition of prostate cancer from androgen dependence to hormone refractory status" @default.
- W2000823230 doi "https://doi.org/10.3892/ijo.32.1.209" @default.
- W2000823230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18097561" @default.
- W2000823230 hasPublicationYear "2008" @default.
- W2000823230 type Work @default.
- W2000823230 sameAs 2000823230 @default.
- W2000823230 citedByCount "2" @default.
- W2000823230 countsByYear W20008232302015 @default.
- W2000823230 crossrefType "journal-article" @default.
- W2000823230 hasAuthorship W2000823230A5006685141 @default.
- W2000823230 hasAuthorship W2000823230A5068782556 @default.
- W2000823230 hasBestOaLocation W20008232301 @default.
- W2000823230 hasConcept C121608353 @default.
- W2000823230 hasConcept C126322002 @default.
- W2000823230 hasConcept C134018914 @default.
- W2000823230 hasConcept C2777911890 @default.
- W2000823230 hasConcept C2779723316 @default.
- W2000823230 hasConcept C2780192828 @default.
- W2000823230 hasConcept C2781018059 @default.
- W2000823230 hasConcept C29537977 @default.
- W2000823230 hasConcept C502942594 @default.
- W2000823230 hasConcept C55493867 @default.
- W2000823230 hasConcept C61367390 @default.
- W2000823230 hasConcept C62112901 @default.
- W2000823230 hasConcept C67082663 @default.
- W2000823230 hasConcept C71315377 @default.
- W2000823230 hasConcept C71924100 @default.
- W2000823230 hasConcept C86803240 @default.
- W2000823230 hasConceptScore W2000823230C121608353 @default.
- W2000823230 hasConceptScore W2000823230C126322002 @default.
- W2000823230 hasConceptScore W2000823230C134018914 @default.
- W2000823230 hasConceptScore W2000823230C2777911890 @default.
- W2000823230 hasConceptScore W2000823230C2779723316 @default.
- W2000823230 hasConceptScore W2000823230C2780192828 @default.
- W2000823230 hasConceptScore W2000823230C2781018059 @default.
- W2000823230 hasConceptScore W2000823230C29537977 @default.
- W2000823230 hasConceptScore W2000823230C502942594 @default.
- W2000823230 hasConceptScore W2000823230C55493867 @default.
- W2000823230 hasConceptScore W2000823230C61367390 @default.
- W2000823230 hasConceptScore W2000823230C62112901 @default.
- W2000823230 hasConceptScore W2000823230C67082663 @default.
- W2000823230 hasConceptScore W2000823230C71315377 @default.
- W2000823230 hasConceptScore W2000823230C71924100 @default.
- W2000823230 hasConceptScore W2000823230C86803240 @default.
- W2000823230 hasLocation W20008232301 @default.
- W2000823230 hasLocation W20008232302 @default.
- W2000823230 hasOpenAccess W2000823230 @default.
- W2000823230 hasPrimaryLocation W20008232301 @default.
- W2000823230 hasRelatedWork W1511886058 @default.
- W2000823230 hasRelatedWork W2082788526 @default.
- W2000823230 hasRelatedWork W2346555178 @default.
- W2000823230 hasRelatedWork W2384115181 @default.
- W2000823230 hasRelatedWork W2772229485 @default.
- W2000823230 hasRelatedWork W2804738061 @default.
- W2000823230 hasRelatedWork W2806371275 @default.
- W2000823230 hasRelatedWork W3012434416 @default.
- W2000823230 hasRelatedWork W3024603101 @default.
- W2000823230 hasRelatedWork W3087152049 @default.
- W2000823230 isParatext "false" @default.
- W2000823230 isRetracted "false" @default.
- W2000823230 magId "2000823230" @default.
- W2000823230 workType "article" @default.